Paper9920878
The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation.
Kisselev AF and 3 others. J Biol Chem, 1999. Cited by 429 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. Papers, record 9920878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9920878
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Cysteine Endopeptidases | Major topic |
| Multienzyme Complexes | Major topic |
| Peptides | Major topic |
| Animals | |
| Chromatography, Gel | |
| Hydrolysis | |
| Muscle, Skeletal | |
| Proteasome Endopeptidase Complex | |
| Proteins | |
| Rabbits | |
| Ubiquitins |
Source PubMed
Cited by167
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 429 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42558228 | Antigen processing machinery deficits in head and neck cancers: mechanisms of immune evasion and strategies for therapeutic restoration. | Front Oncol | 2026 | https://conductscience.org/library/papers/42558228 | PubMed |
| 42539287 | Molecular basis of ubiquitin-independent recognition and degradation of ODC/Antizyme by the 26S proteasome. | bioRxiv | 2026 | https://conductscience.org/library/papers/42539287 | PubMed |
| 41807387 | Molecular insights into the regulation of GNPTαβ by LYSET. | Nat Commun | 2026 | https://conductscience.org/library/papers/41807387 | PubMed |
| 41516338 | Transmission of Non-Constitutive Proteasomes Between Cells via Extracellular Vesicles. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41516338 | PubMed |
| 41273382 | Luminespib protects against dexamethasone-induced hepatic, vascular, and metabolic abnormalities in rats. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41273382 | PubMed |
| 40653420 | Proteasome-derived peptides: separating the trash from the recycling. | Trends Biochem Sci | 2025 | https://conductscience.org/library/papers/40653420 | PubMed |
| 40563520 | Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis. | Biomolecules | 2025 | https://conductscience.org/library/papers/40563520 | PubMed |
| 40538982 | Proteasome caspase-like activity regulates stress granules and proteasome condensates. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40538982 | PubMed |
| 40189142 | ERAP1 Activity Modulates the Immunopeptidome but Also Affects the Proteome, Metabolism, and Stress Responses in Cancer Cells. | Mol Cell Proteomics | 2025 | https://conductscience.org/library/papers/40189142 | PubMed |
| 40044870 | Cell-autonomous innate immunity by proteasome-derived defence peptides. | Nature | 2025 | https://conductscience.org/library/papers/40044870 | PubMed |
| 39990094 | Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39990094 | PubMed |
| 39411061 | Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39411061 | PubMed |
| 39180935 | From the TOP: Formation, recognition and resolution of topoisomerase DNA protein crosslinks. | DNA Repair (Amst) | 2024 | https://conductscience.org/library/papers/39180935 | PubMed |
| 38472306 | Hats off to 20S proteasome substrate discovery. | Mol Syst Biol | 2024 | https://conductscience.org/library/papers/38472306 | PubMed |
| 38326304 | Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing. | Nat Commun | 2024 | https://conductscience.org/library/papers/38326304 | PubMed |
| 38260042 | Decoding the secrets: how conformational and structural regulators inhibit the human 20S proteasome. | Front Chem | 2023 | https://conductscience.org/library/papers/38260042 | PubMed |
| 37762148 | Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers-Protein Interactions. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762148 | PubMed |
| 37759700 | A Lysine Residue at the C-Terminus of MHC Class I Ligands Correlates with Low C-Terminal Proteasomal Cleavage Probability. | Biomolecules | 2023 | https://conductscience.org/library/papers/37759700 | PubMed |
| 37508510 | Targeted Protein Degradation: Principles and Applications of the Proteasome. | Cells | 2023 | https://conductscience.org/library/papers/37508510 | PubMed |
| 37217651 | The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC. | Nat Cancer | 2023 | https://conductscience.org/library/papers/37217651 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9920878
GET https://conductscience.org/api/papers/v1/9920878/cited_by?page=2